Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

qBotica to Acquire Healthomation to Expand Healthcare Automation Capabilities

qBotica Inc, a leading technology and automation solutions provider, is proud to announce its strategic investment in Healthomation Inc, a healthcare automation company, to further its suite of offerings and expand its reach within the healthcare sector. Healthomation Inc is at the forefront of healthcare process automation, similar to industry competitors like Olive.AI.

This strategic partnership brings together the extensive expertise and innovative capabilities of both companies to drive transformative changes in healthcare through the power of Artificial Intelligence (AI) and Machine Learning (ML) technologies. By joining forces, qBotica and Healthomation aim to address the ever-growing demand for automation and efficiency in healthcare, ultimately improving patient care and streamlining operations for healthcare providers, and revenue cycle management vendors.AIThority Predictions Series 2024 banner

Recommended AI News: Riding on the Generative AI Hype, CDP Needs a New Definition in 2024

qBotica’s CEO, Mahesh Vinayagam, expressed his enthusiasm for this significant step forward, stating, “Our investment in Healthomation Inc represents a pivotal moment for qBotica, as we align ourselves with a cutting-edge company that shares our commitment to innovation and excellence. This collaboration will allow us to harness the power of AI and ML to create RPA solutions that transcend the healthcare sector’s traditional boundaries. We are excited to work together to bring about positive changes in the industry.”

Healthomation Inc’s CEO, Selvaraj Murugaiyan, also shared his thoughts on the partnership, saying, “We are thrilled to have qBotica Inc as a strategic partner in our mission to advance healthcare automation. With their proven track record in Robotic process automation and document understanding solutions, we believe qBotica is the perfect partner to help us revolutionize healthcare delivery. Our combined efforts will enable us to provide healthcare organizations and RCM vendors with AI-driven automation tools that eases integration between EHRs, enhance efficiency, reduce operational costs, and improve the overall patient experience.”

Related Posts
1 of 40,972

Recommended AI News: Rocket Mortgages Pathfinder Reaches New Heights Using Automation, AI and Machine Learning

This strategic investment will facilitate the development of innovative automation solutions combining EDI and RPA that can drive integrations, efficiency, accuracy, and consistency in healthcare processes, from administrative tasks to patient care. By harnessing the power of AI and ML, EDI and RPA qBotica and Healthomation Inc aim to provide healthcare organizations and RCM vendors with the tools and resources necessary to thrive in an increasingly complex and demanding industry.

Recommended AI News: Rockwell Automation and Microsoft Expand Partnership to Leverage Generative AI Capabilities

Expion Health, formerly known as Exponent Health, recently received the esteemed AI-10 award from UiPath for its outstanding use of AI and Automation to streamline company processes. Collaborating with qBotica, a trailblazer in AI-driven automation solutions, Expion Health demonstrates its commitment to harnessing the power of automation, positioning itself at the technological vanguard of the healthcare sector. This accolade underscores how innovative partnerships and a forward-thinking approach can reshape the future of healthcare delivery.

[To share your insights with us, please write to sghosh@martechseries.com]

Comments are closed.